ECDC Advocates Advocates make a specific effort to reduce the number of hepatitis B (HBV), hepatitis C (HCV) and HIV testing programs to reduce the number of people currently infected but not diagnosed. They need to integrate comprehensive test strategies or programs in six core tests to respect principles and apply individualized needs:
- Tests must be approved, voluntary, confidential and informed consent.
- Good information should be tested before and after.
- The monitoring link is a critical part of the effective testing program.
- Standardization of HBV, HCV and HIV testing in all health settings; and
- HIV / AIDS, HBV and / or HCV testing should receive appropriate training and education.
- An effective national efficiency strategy, including the monitoring and evaluation framework, is critical for responding to HBV, HCV and HIV infections.
The success of the increase in the growth of studies should be aimed at preventing the removal of HIV and viral hepatitis for 2030 for public health, as explained by the Sustainable Development Goals.
The ECDC Guidelines show where, how and when to treat viral hepatitis and HIV, and to try out strategies that apply to self-sampling and self-concept. Due to the higher risk of infection, the population of the population that is suitable for HBV, HCV and / or HIV examinations have sex with men, relatives, sex workers, sexually aggressive, pregnant women or hemodialysis patients. Examples of good guidance practices include primary care settings, hospitals, ITS clinics, pharmaceuticals, prisons, and community settings, including drug and diminishing services.
Integrated test: health benefits and "synergies that respect the resources borders"
"If we want to maximize the benefits of viral hepatitis or viral hepatitis, it is critical to try and diagnose it as soon as possible, which is a challenge because three infections are asymptomatic years, according to ECDC estimates, which has been on average for a period of three years for the diagnosis of HIV infection. That's too long ", notes Director of Andrea Ammon, Director of ECDC. "Our new analysis guidelines provide many opportunities for testing in national or local testing interventions, in different settings, and at risk populations, one of the key elements that allows diversification and integration of testing services, allowing synergies over resources limitations because it has it. "
Early surveillance and diagnosis can be beneficial to the individual and the public for health: it eliminates or eliminates viral or viral hepatitis viral HIV, which at the same time means that the treatments stop interrupting the existing transmission channels and prevent further infections.
However, more people with no EC or EU chronic hepatitis B or C are not aware of the infection and, as a result, they do not receive treatment.
Vytenis Andriukaitis, European Commissioner for Health and Food Safety, said: "The advances in antiretroviral therapy have changed the epidemic of the HIV epidemic in Europe – HIV is not a serious illness. People who have been diagnosed with one month and have received effective treatment have become a chronic condition of the HIV, as the intensive trials of the last decade progressed, According to seven people living with EU HIV / EVE, they have not yet been diagnosed, we need to focus on social efforts to weaken social vulnerabilities. We need to increase the effort to test B hepatitis B and C, a disease that affects 9 million people in the European Union. We have to deal with each other to achieve our Goal for Sustainable Development, which is why I and the European Commission are in favor of the European Proba Week. "
The European Week of Proba Week will begin today, over 700 organizations across Central Asia, to promote dialogue between those who try and offer texts. Early diagnosis of HIV and early viral hepatitis benefits everyone.